Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3 - Wikidata - wikimedia - TriplyDB

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

http://www.wikidata.org/entity/Q33772149

about

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease The role of the CD58 locus in multiple sclerosis B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions Remyelination therapy for multiple sclerosis Gut commensalism, cytokines, and central nervous system demyelination Multiple sclerosis: the role of cytokines in pathogenesis and in therapies Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action Life sciences and biotechnology in China.Infection risk in patients on multiple sclerosis therapeutics.Effects of natalizumab treatment on Foxp3+ T regulatory cells.Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice.A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.Analysis of the transcriptional program of developing induced regulatory T cells Immune regulation of multiple sclerosis by CD8+ T cells Inhibition of experimental autoimmune uveitis by amino acid copolymers Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma.A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).Glatiramer acetate for treatment of MS: regulatory B cells join the cast of players.CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.Homo-β-amino acid containing MBP(85-99) analogs alleviate experimental autoimmune encephalomyelitis.The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.T regulatory cells: aid or hindrance in the clearance of disease?Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA Influence of Interferon-γ Deficiency in Immune Tolerance Induced by Male Islet Transplantation Intravenous tolerance effectively overcomes enhanced pro-inflammatory responses and experimental autoimmune encephalomyelitis severity in the absence of IL-12 receptor signaling.Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?Antigen-specific therapies in multiple sclerosis.Interferon beta and glatiramer acetate therapy.The role of dendritic cells in the generation of CD4(+) CD25(HI) Foxp3(+) T cells induced by amino acid copolymers Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis Mechanism of action of glatiramer acetate in treatment of multiple sclerosis.Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma.Innate and adaptive immunity for the pathobiology of Parkinson's disease Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.

P2860

Q21135577-EB99A3A9-834A-4DDE-AD96-40F00D1B7DE2 Q24649291-C1E0A464-D851-49AB-9875-26E8F4F27E6E Q26770664-03A6BD63-2374-4CDA-BBDE-F0C59CFB6947 Q26824246-E884D7E9-BED7-4823-A87E-A8578B0D6033 Q26863405-859C04BA-FA0B-4F07-9095-1A6E51045F0C Q27011014-E8CB2802-0B6F-4CC5-B6BF-29A952DD818C Q28308287-DF1A1921-904A-44B3-94AA-A7DE71E8EAB1 Q28757874-FC1E2C10-675B-4261-BD41-824EB9048971 Q30908652-DA262092-597F-4D9A-8163-1F16121E8D7C Q33373995-AB7F30AE-8E44-4033-B034-C1605A15A6FD Q33695905-E8C767DF-400D-4A38-83EE-9D80DAA39710 Q33769952-EB7BF109-98FB-48F0-9CDD-2DF5A5C8E119 Q33828647-2AEDEC36-1F30-45BB-8A31-93333BC490BC Q34017004-92416498-D38B-4862-A826-D53032CC1341 Q34083323-F0C7363E-158A-4A60-8DE1-31C1F9BFFF0A Q34184819-5F384560-45FC-4B36-AD61-84DB8CD397D4 Q34409308-4E16007E-FEAD-4101-9636-FF07221A0213 Q34479298-B44B0502-4547-4314-BD7F-E517ED5D6D73 Q34785580-EBA978ED-2C28-4959-AB07-61C447676EED Q35040831-2C7BF994-5263-4066-82E2-6B35490218EF Q35105313-ED499467-174C-4E43-8797-C2C0863D63C9 Q35276622-DEA4BD48-330D-45CE-B457-50E88D63B716 Q35459820-04C82DE5-A01C-4C0A-AFC4-F8010728CF82 Q35606563-654D01C9-4659-4F56-AF36-E4935A48DB0D Q35627540-487513ED-83C6-4344-B1F2-6A218FAA9018 Q35745499-62790D51-F3CB-47B2-8686-F2278963BEDD Q35957480-1D16750F-F3EB-4F4E-A420-917203EDDC1C Q36018333-5A1AD65E-F9DE-45CA-9C71-DE715ED0C377 Q36034499-A5E489F1-EEBB-4702-88D3-0EB066B4CB25 Q36095922-AF151CCD-23F8-41FD-B2FF-BFCD4491B3E1 Q36171406-42E0691C-A0C6-4B32-9242-2D480E6BEB42 Q36327373-02B39A33-2CDC-43BF-839E-BB0467710E9C Q36568660-0C3BB620-7E26-4D1F-87B7-D8BA1816EB47 Q36749505-AC6ADA72-1DF3-470D-B8E1-5CB0F90449A2 Q36791390-B8EF8714-3B7D-499C-8C9F-4E038E844C86 Q36963184-54364E05-8048-4BAC-9F0E-13C3394DCFF5 Q37053851-32CE250B-41C8-4740-AC42-476FE3ED670B Q37299722-E6ADC822-3DCE-4850-8AA0-737DA027D767 Q37401280-8F27D222-66A3-4614-97A7-7F419F80BE2D Q37580266-FCC3F91F-F411-4CD8-A92F-C02654D4220A

P2860

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

http://www.wikidata.org/entity/Q33772149

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@ast

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@en

type

label

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@ast

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@en

prefLabel

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@ast

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@en

P1433

Q33772149-78BEF879-9309-4867-A9BD-5B0FAFB5D7C7

P1476

Q33772149-3E361E84-6E8C-4E41-B77D-CF6879CA50FE

P2093

Q33772149-0694C25F-F8A7-4B12-88E7-57FD44C0F670

Q33772149-4BD8B7DB-5AE6-4E2C-9267-73EF22F66FDA

Q33772149-86100197-0F24-48F1-8DA9-0B48651FF626

Q33772149-BA904DE5-E834-4D45-844F-F88C83E9188D

Q33772149-E4D52395-6867-45DD-9199-510EC1CB464E

P2860

Q33772149-078A078D-3327-49F6-811C-FD8C76E47F47

Q33772149-199A2BD5-3270-40D2-A826-ED1094E01CE3

Q33772149-26DD2268-5F29-4C55-9518-D0525BF5BB08

Q33772149-2F229DCF-4B77-42AB-BD18-6F30B3E005FD

Q33772149-3624D031-8E4C-4C56-9C8D-76DA5DA57F8B

Q33772149-3A7902A8-3A82-4F88-9585-9DC4DEC0F0E7

Q33772149-3F36930B-36BB-4E33-A834-7ED9CCF64300

Q33772149-4B9125DC-AF54-4E25-A2F1-070573AE10B7

Q33772149-5A596CCD-7D2F-4AD7-8F9E-98091507492C

Q33772149-5F428453-D178-44E6-9B3E-01A0AC9997DA

P304

Q33772149-942F8BB7-0505-495E-9394-9711CE5720BD

P31

Q33772149-AF43539E-80D7-44D5-8036-704B3AD5A809

P356

Q33772149-63F1E0D7-6E31-44EB-9BF2-4E522B130477

P407

Q33772149-26B7997A-2235-4577-B113-02F16610EA41

P433

Q33772149-3C65E337-896F-4ECC-8C3F-C938892B673B

P478

Q33772149-4CCE56B9-4FDB-4EAE-94EB-07B588A60BC3

P577

Q33772149-8EAE4563-7C70-4AD6-AADA-832DF01199B9

P5875

Q33772149-162CAEEE-5E52-4292-95AD-02EF2392C68E

P698

Q33772149-237CA20F-A8AA-4FE0-9659-ECAF07D8E715

P932

Q33772149-E5EEEAD6-2C9F-45C7-9523-824FF3A532AC

P356

PNAS.0502187102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Induction of CD4+CD25+ regulat ...... of transcription factor Foxp3

@en

P2093

Biao Zheng

http://www.w3.org/2001/XMLSchema#string

Jian Hong

http://www.w3.org/2001/XMLSchema#string

Jingwu Z Zhang

http://www.w3.org/2001/XMLSchema#string

Ningli Li

http://www.w3.org/2001/XMLSchema#string

Xuejun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease.

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Multiple immuno-regulatory defects in type-1 diabetes

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

An essential role for Scurfin in CD4+CD25+ T regulatory cells

P304

6449-6454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0502187102

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7885617

http://www.w3.org/2001/XMLSchema#string

P698

15851684

http://www.w3.org/2001/XMLSchema#string

P932

1088385

http://www.w3.org/2001/XMLSchema#string